Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
mCPP: an undesired addition to the ecstasy market.
Bossong MG, Brunt TM, Van Dijk JP, Rigter SM, Hoek J, Goldschmidt HM, Niesink RJ. Bossong MG, et al. Among authors: niesink rj. J Psychopharmacol. 2010 Sep;24(9):1395-401. doi: 10.1177/0269881109102541. Epub 2009 Mar 20. J Psychopharmacol. 2010. PMID: 19304863
Methylone and mCPP, two new drugs of abuse?
Bossong MG, Van Dijk JP, Niesink RJ. Bossong MG, et al. Among authors: niesink rj. Addict Biol. 2005 Dec;10(4):321-3. doi: 10.1080/13556210500350794. Addict Biol. 2005. PMID: 16318952
Acute toxic effects related to 4-fluoroamphetamine.
Wijers CH, van Litsenburg RT, Hondebrink L, Niesink RJ, Croes EA. Wijers CH, et al. Among authors: niesink rj. Lancet. 2017 Feb 11;389(10069):600. doi: 10.1016/S0140-6736(17)30281-7. Lancet. 2017. PMID: 28195054 No abstract available.
Is online information on ecstasy tablet content safe?
Vrolijk RQ, Brunt TM, Vreeker A, Niesink RJ. Vrolijk RQ, et al. Among authors: niesink rj. Addiction. 2017 Jan;112(1):94-100. doi: 10.1111/add.13559. Epub 2016 Sep 21. Addiction. 2017. PMID: 27518128
46 results